- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03424434
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017 (OBE PRACTITIONERS UHC 2017)
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017
Descripción general del estudio
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Clermont-Ferrand, Francia, 63003
- Chu Clermont-Ferrand
-
La Tronche, Francia, 38700
- Chu Grenoble Alpes
-
Pierre-Bénite, Francia, 69495
- Groupement Hospitalier Sud
-
Saint-Étienne, Francia, 42055
- CHU de Saint-Etienne
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Any medical or surgical health professional
- practitioner and resident
- working in an UHC
- without distinction of medical or surgical specialty
- having a professional mailbox
Exclusion Criteria:
- All paramedical health professionals (example: nurses) and pharmacists
- Any medical or surgical health professional working full-time outside an UHC
- Any medical or surgical health professional with exclusive liberal activity outside an UHC
- Administrative and technical staff of an UHC
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Medical staff of an UHC, practitioners and residents
The target population is practitioners and residents who works at hospital in an UHC, they are also specialists, surgeons, dental surgeons.
|
The study consists in a survey diffusion during several weeks by emailing each practitioner and resident and inviting them to participate to a questionnaire about occupational blood exposure.
This survey is strictly anonymous.
No identity data is required, only age, gender, function, surgical or medical specialty, work quota and hospital group they belong.
This survey is diffused in four UHC (Lyon, Grenoble, Clermont-Ferrand and Saint-Etienne) in France.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Evaluation of underreporting occupational blood exposure (OBE) among the medical staff at an University Hospital Center (UHC) for the year 2017
Periodo de tiempo: 1 day
|
This evaluation consists in collecting, during the diffusion of a survey, the number of OBE the medical professional is victim of and the number of OBE is reported to deduce the number of non-reported OBE, over the period of interest which is the year 2017.
|
1 day
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The occurrence circumstances of OBE
Periodo de tiempo: 1 day
|
These questions are gathered in a table and concern different sorts of contaminated needlesticks, blood projections, cut or wound and the positive serologic status for the source patient. This specific outcome is qualitatively evaluated with questions relating to the occurence circumstances of OBE with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
The part of each factor, related to the professional activity and to the OBE itself, in the OBE reporting.
Periodo de tiempo: 1 day
|
Some questions are gathered in a table and propose 15 differents reasons that can condition the OBE reporting, such as lack of time, fear of judgment, repetition of OBE, unknowing of reporting procedure, lack of standards precautions, only antisepsis maneuvers sufficient, source patient considered as safe, procedure to report considered complex, fear of career consequences, lack of witness, night work, negatives serologies for the source patient, fear of the serological follow-up, fear observing an antiretroviral treatment, ignorance that an OBE was a true one. For each factor, a percentage will be measured as indicative of its importance in the OBE underreporting. This specific outcome considering various factors that can influence the reporting of an OBE is evaluated by several questions with a yes or no answer. |
1 day
|
|
Involvement of behaviors of underreporting medical professionals
Periodo de tiempo: 1 day
|
Using two tables, several measures recommanded about the biological risk in hospital environment (including OBE) are discussed. These differents measures are considered as primary and secondary preventive behaviors. For each measure, we examine its frequency as indicative of its implication in the OBE underreporting. This outcome is evaluated with questions on vaccination, immunization, wearing of personal protective equipment and realization of the antisepsis maneuvers, realization of serologies for source patient and personal ones, with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
Practitioners knowledges about the specific infectious risk of OBE
Periodo de tiempo: 1 day
|
On a first table, the participant has to choose one of the four rates proposed (30% - 1 to 3% - 0,3% - < 0,3%) to evaluate the risk of seroconversion after percutaneous contact with infected blood by HIV or hepatitis B virus (HBV) or hepatitis C virus (HCV). On a second table, the participant has to choose a time limit (Immediately - within 4 hours - within 48 hours - up to 7 days) for different situations near OBE occurence, it concerns antisepsis maneuvers, prophylactic antiretroviral treatment, initial personal serological status and source patient serological status. A test is proposed to evaluate knowledges about the infectious risk related to OBE, this test is optional, grouping together seven simple choice questions. |
1 day
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 69HCL17_0883
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Health Professional
-
University of Dublin, Trinity CollegeDesconocidoAtletas de élite retirados de Brain Health
-
Queens College, The City University of New YorkReclutamientoPublicación de artículos enviados al American Journal of Public HealthEstados Unidos
-
WestatPlasma Protein Therapeutics AssociationAún no reclutandoHealth Effects (Niveles de Ferritina, Niveles de PCR, Niveles de IgG, Salud Auto-reportada)Estados Unidos
Ensayos clínicos sobre Survey diffusion
-
University of OxfordTerminadoUso de antibióticosTailandia
-
AIDS Arms Inc.Terminado
-
Zoe Global LimitedTerminado
-
University of EdinburghNHS LothianTerminado
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Fund for Scientific Research, Flanders, BelgiumReclutamientoDolor crónico | Neoplasia De Mama | Carcinoma de mamaBélgica
-
Centre Hospitalier Universitaire de NīmesTerminado